入院时D-二聚体与纤维蛋白原比值对进展性脑梗死的预测价值

doi:10.3969/j.issn.1671-7171.2026.08.025

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1223 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To investigate the predictive value of the D-dimer-to-fibrinogen ratio (DFR) at admission for progressive cerebral infarction. 【Methods】 A total of 92 patients with acute cerebral infarction admitted to our hospital from February 2022 to May 2025 were enrolled. The levels of D-dimer and fibrinogen were measured at admission, and the DFR was calculated. The National Institutes of Health Stroke Scale (NIHSS) scores were assessed at admission and 72 h after admission. Progressive cerebral infarction was defined as an increase of ≥4 points in the NIHSS score within 72 h (the progression group). The differences in DFR between the progression group and non-progression group were compared. Multivariate Logistic regression analysis was performed to evaluate the correlation between DFR and progressive cerebral infarction. Receiver operating characteristic (ROC) curves were plotted to assess the predictive performance of DFR. 【Results】 Among the 92 patients, 22 developed progressive cerebral infarction, accounting for 23.91%. The DFR in the progression group was significantly higher than that in the non-progression group (P<0.05). Multivariate logistic regression analysis showed that, after adjustment for confounding factors including age, baseline NIHSS score, history of atrial fibrillation, and intravenous thrombolysis, DFR ≥0.27 remained an independent predictor of progressive cerebral infarction (OR=4.908, P<0.05). ROC curve analysis showed that the AUC of DFR for predicting progressive cerebral infarction within 72 h was 0.859 and the optimal cutoff value was 0.27, with a sensitivity of 77.3% and a specificity of 78.6%. 【Conclusion】 An elevated DFR at admission is associated with an increased risk of progressive cerebral infarction within 72 h. DFR has certain predictive value for progressive cerebral infarction and may serve as an auxiliary indicator for early risk stratification in patients with acute cerebral infarction.

Key words： Brain Infarction D-dimer Fibrinogen

Received: 04 January 2026

PACS:

R743.33

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GUO Yanli
	LIU Shuang
	LEI Pei

Cite this article:

GUO Yanli,LIU Shuang,LEI Pei. Predictive Value of D-Dimer-to-Fibrinogen Ratio for Progressive Cerebral Infarction[J]. JOURNAL OF CLINICAL RESEARCH, 2026, 43(8): 1322-1325.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2026.08.025 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2026/V43/I8/1322

[1] 云静,邓春颖,左俊琴,等. 血常规及凝血相关指标与急性穿支动脉粥样硬化性脑梗死早期病情进展关系的研究[J].中华老年心脑血管病杂志,2024,26(8):906-910.
[2] 马琳颖,崔啸宇,邓春颖,等. 血管衰老指标与急性脑梗死早期病情进展的相关性研究[J].中国医药,2025,20(5):688-692.
[3] 马瑞祥,刘艺,薛玉英,等. ADPN、hs-CRP/ALB比值与急性脑梗死病情进展的关系分析[J].中国基层医药,2025,32(3):420-425.
[4] 杜诚,孔德莲,韦存胜,等. WORSEN评分联合中性粒细胞与淋巴细胞比值对进展性卒中的预测价值[J].中国实用神经疾病杂志,2025,28(3):294-299.
[5] 郝劲松. D-二聚体、同型半胱氨酸、血栓弹力图与进展性脑梗死的相关性分析[J].临床医学研究与实践,2025,10(26):59-62.
[6] 赵媛,陈彬,张拥波,等. 发病时年龄、入院时基线NIHSS评分及中性粒细胞/淋巴细胞对急性后循环脑梗死患者发病14 d内临床加重的预测价值[J].临床和实验医学杂志,2025,24(12):1237-1241.
[7] 中华人民共和国国家卫生健康委员会. 脑血管病防治指南(2024年版)[J].磁共振成像,2025,16(1):1-8.
[8] 杨娟娟,李晓童,代素雅. D-二聚体预测依达拉奉右莰醇治疗进展性脑梗死后病灶面积改善的价值[J].国际医药卫生导报,2025,31(18):3011-3016.
[9] 王昌铭,龚慧,赵淑娟,等. 老年脑梗死后血管性认知功能障碍患者不同血清标志物的表达及其临床意义[J].中华老年心脑血管病杂志,2023,25(7):733-737.
[10] 尹涛,姜丽真,张盟盟,等. 老年短暂性脑缺血发作患者进展为脑梗死的危险因素及ABCD2评分、血液指标的诊断价值[J].中国老年学杂志,2023,43(19):4622-4626.
[11] 殷香,牛玉莲. 双重抗血小板联合丁苯酞治疗进展性脑梗死的预后因素分析[J].新疆医科大学学报,2023,46(6):763-767.
[12] 李宏锦,李景莉,李亚楠,等. 血压晨峰及血栓弹力图与进展性脑梗死的相关性分析[J].中国实用神经疾病杂志,2023,26(9):1062-1067.
[13] 秦晓琴,闫小娜,李存英,等. 血清可溶性细胞间黏附分子-1、基质金属蛋白酶-9和C反应蛋白水平与进展性脑梗死患者颈动脉斑块稳定性的相关性[J].新乡医学院学报,2025,42(10):859-863.
[14] 范玉红,李丽,张慧,等. 曲克芦丁联合替罗非班治疗急性进展性脑梗死的临床研究[J].现代药物与临床,2024,39(8):2006-2011.